Literature DB >> 17004133

The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.

Luísa Rolim1, José A Zagalo-Cardoso, Constança Paúl, Jorge Sequeiros, Manuela Fleming.   

Abstract

This study describes the construction of a self-response inventory to evaluate the perception of advantages and disadvantages of the Machado-Joseph disease presymptomatic testing, in 44 individuals at-risk for this disease. The results showed that the reliability of this inventory was satisfactory. Factor analysis revealed a bidimensional structure: perceived advantages (pros) and perceived disadvantages (cons) of presymptomatic testing. Social desirability was found unrelated to the total scores of our inventory. Additional correlation studies, with other scales, confirmed the convergent validity of the instrument. These results suggest adequate construct validity. This inventory thus seems to be a proper instrument to assess expectations involved in the decision-making process of Machado-Joseph disease presymptomatic testing.

Entities:  

Mesh:

Year:  2006        PMID: 17004133     DOI: 10.1007/s10897-006-9033-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  28 in total

1.  An experimental study of influences on the perceived likelihood of seeking genetic testing: "nondirectiveness" may be misleading.

Authors:  P M Salkovskis; R Dennis; A L Wroe
Journal:  J Psychosom Res       Date:  1999-11       Impact factor: 3.006

2.  Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts.

Authors:  K K Nakano; D M Dawson; A Spence
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

3.  Psychosocial genetics: an emerging scientific discipline.

Authors:  P S Harper
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

Review 4.  Predictive testing for Huntington disease: a psychologist's view.

Authors:  S Kessler
Journal:  Am J Med Genet       Date:  1994-09-15

5.  Figuring out factors: the use and misuse of factor analysis.

Authors:  D L Streiner
Journal:  Can J Psychiatry       Date:  1994-04       Impact factor: 4.356

6.  Predictive genetic diagnosis.

Authors:  A G Motulsky
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

7.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea.

Authors:  A Tyler; P S Harper
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

9.  Predictive testing for Huntington's disease with use of a linked DNA marker.

Authors:  G J Meissen; R H Myers; C A Mastromauro; W J Koroshetz; K W Klinger; L A Farrer; P A Watkins; J F Gusella; E D Bird; J B Martin
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

Review 10.  Risks and benefits of DNA testing for neurogenetic disorders.

Authors:  T D Bird
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

View more
  1 in total

1.  Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal.

Authors:  Lavínia Schuler-Faccini; Claudio Maria Osorio; Flavia Romariz; Milena Paneque; Jorge Sequeiros; Laura Bannach Jardim
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.